United Therapeutics | UTHR - Pre Tax Profit


United Therapeutics reported $372.7M in Pre-Tax Profit for its fiscal quarter ending in June of 2026.





Pre Tax Profit Change Date
Amarin USD -852K 7.26M Dec/2025
Ardelyx USD -37.6M 37.2M Mar/2026
Baxter International USD 362M 368M Jun/2026
Bayer EUR 2.99B 6.36B Mar/2026
BioCryst Pharmaceuticals USD 248.02M 235.89M Dec/2025
Biogen USD 647.3M 269.6M Jun/2026
BioMarin Pharmaceutical USD 141.2M 168.36M Mar/2026
Gilead Sciences USD -7.53B 10.11B Jun/2026
GlaxoSmithKline GBP 2.68B 532M Jun/2026
Halozyme Therapeutics USD 180.33M 281.18M Mar/2026
Insmed USD -11.37M 150.72M Jun/2026
Ionis Pharmaceuticals USD -114M 21M Jun/2026
J&J USD 8.66B 839M Jun/2026
Lexicon Pharmaceuticals USD -12.77M 16.02M Sep/2025
Moderna USD -1.33B 535M Mar/2026
Omeros USD -65.12M 21.27M Jun/2024
Pfizer USD -653M 5.84B Jun/2026
PTC Therapeutics USD -2.46M 136.62M Mar/2026
Regeneron Pharmaceuticals USD 1.53B 696.6M Jun/2026
Sangamo BioSciences USD -36.05M 12.94M Jun/2024
Sarepta Therapeutics USD -1.75M 344.92M Jun/2026
Teva Pharmaceutical Industries USD -455M 1.21B Jun/2026
United Therapeutics USD 372.7M 54.4M Jun/2026
Vertex Pharmaceuticals USD 1.25B 78.1M Mar/2026